Publications by authors named "Didier Esquieu"

Claim this Profile
T
Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties.
Grant R Campbell, David Senkaali, Jennifer Watkins, Didier Esquieu, Sandrine Opi

Vaccine· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Alexander A Makarov, Philipp O Tsvetkov, Claude Villard, Didier Esquieu, Bertrand Pourroy

Biochemistry· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine.
Jennifer D Watkins, Sophie Lancelot, Grant R Campbell, Didier Esquieu, Jean de Mareuil

Retrovirology· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells.
Grant R Campbell, Jennifer D Watkins, Didier Esquieu, Eddy Pasquier, Erwann P Loret

J Biol Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 Tat protein enhances microtubule polymerization.
Jean de Mareuil, Manon Carre, Pascale Barbier, Grant R Campbell, Sophie Lancelot, Didier Esquieu

Retrovirology· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis.
Grant R Campbell, Eddy Pasquier, Jennifer Watkins, Veronique Bourgarel-Rey, Vincent Peyrot, Didier Esquieu

J Biol Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full-length HIV-1 Tat protein necessary for a vaccine.
Sandrine Opi, Jean-Marie Péloponèse, Didier Esquieu, Jennifer Watkins, Grant Campbell

Vaccine· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor.
Mickaël Montembault, Giang Vo-Thanh, Abdallah Deyine, Valérie Fargeas, Monique Villiéras, Didier Esquieu

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants.
Sandrine Opi, Jean-Marie Péloponèse, Didier Esquieu, Grant Campbell, Jean de Mareuil

J Biol Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis